BioAdaptives Inc (BDPT)

[MC10459]

This looks good to me:

Edward Jacobs, M.D., CEO of BioAdaptives,Inc., comments, “We are very pleased that the timely separation and delineation of activities for each of the two companies is in concert with the appointments of new Directors with individual relevant expertise.

“Although the separation of these areas is designed to be efficient, we know that there is a common benefit for everyone because of the inherent and continual cross-over of knowledge among human and animal health endeavors. We continue to reach out to potential domestic and international collaborators to build a more diverse and global enterprise.”

In addition, with the new realigned functions and products, where botanical drugs development being a LiveStock Impact, Inc. function, Dr. Yagang Liu and Dr. David Allen have now joined the Board of Directors of LiveStock Impact, Inc. and resigned from BioAdaptives, Inc. Their anticipated contribution to the development of various botanical drugs, including several patented by Dr. Liu, would be much valued here.